Galenica AG (GALE.SW)
- Previous Close
70.35 - Open
70.40 - Bid --
- Ask --
- Day's Range
69.70 - 70.85 - 52 Week Range
65.10 - 80.05 - Volume
80,414 - Avg. Volume
75,369 - Market Cap (intraday)
3.531B - Beta (5Y Monthly) 0.18
- PE Ratio (TTM)
21.40 - EPS (TTM)
3.31 - Earnings Date Mar 12, 2024
- Forward Dividend & Yield 2.20 (3.11%)
- Ex-Dividend Date Apr 12, 2024
- 1y Target Est
76.50
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data system for the healthcare market; develops management solutions for the healthcare market; group internal IT services; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
www.galenica.com4,459
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: GALE.SW
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GALE.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GALE.SW
Valuation Measures
Market Cap
3.53B
Enterprise Value
3.65B
Trailing P/E
21.40
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.94
Price/Book (mrq)
2.40
Enterprise Value/Revenue
0.97
Enterprise Value/EBITDA
11.87
Financial Highlights
Profitability and Income Statement
Profit Margin
7.60%
Return on Assets (ttm)
4.27%
Return on Equity (ttm)
12.16%
Revenue (ttm)
3.76B
Net Income Avi to Common (ttm)
164.92M
Diluted EPS (ttm)
3.31
Balance Sheet and Cash Flow
Total Cash (mrq)
116.16M
Total Debt/Equity (mrq)
49.21%
Levered Free Cash Flow (ttm)
150.72M
Research Analysis: GALE.SW
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: GALE.SW
GALE.SW does not have Company Insights